$MEDS Enters First Agreement to Supply COVID-19 Testing Kits

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced entry into its first Covid-19 antibody testing kits supply agreement with law firm McIntyre Thanasides Bringgold Elliott Grimaldi Guito & Matthews, P.A. According to the update, the midsized Tampa firm will today begin periodic testing of its employees and their families, and the partnership will promote a safer working environment and increase Covid-19 exposure risk awareness. Trxade’s Integra Pharma Solutions, LLC subsidiary will provide antibody rapid blood test kits, intended to be administered at point of care with no additional instrumentation needed, and Accomplished Home Health Care staff will perform the testing. “As we start bringing more employees back to the office, we believe that it is important to take additional precautions to protect them. Trxade offers a relatively inexpensive supply solution that delivers quick results. Accomplished Home Health Care provides the medical supervision to ensure that the tests and results are being used appropriately,” the law firm’s President Richard J. McIntyre said in the news release. “We are very grateful to have both of them as partners in this battle against the coronavirus.”

To view the full press release, visit http://nnw.fm/D9j5W

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASQAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual Wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same day or mail order pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://nnw.fm/MEDS

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.